Table 1 Patients characteristics
Characteristics | n (%) | |||
|---|---|---|---|---|
Gender | Male | 36 (55%) | ||
Female | 30 (45%) | |||
Medulloblastoma | 16 (24%) | |||
Ependymoma and ependymoblastoma | 8 (12%) | |||
Glioma | 7 (11%) | |||
CNS | Pineoblastoma | 2 (3%) | ||
Teratoid/Rhabdoid tumor | 2 (3%) | |||
Germinal tumor | 1 (1%) | |||
Choroid plexus tumor | 1 (1%) | |||
Craniopharyngioma | 1 (1%) | |||
Tumor site/histology | Abdomen | Neuroblastoma | 7 (11%) | |
Nephroblastoma | 2 (3%) | |||
Rhabdomyosarcoma | 1 (1%) | |||
Clear cell sarcoma | 1 (1%) | |||
Thorax | Ewing sarcoma | 1 (1%) | ||
Hodgkin lymphoma | 1 (1%) | |||
PNET (Askin's) tumor | 1 (1%) | |||
Rhabdomyosarcoma | 1 (1%) | |||
Pelvis | Rhabdomyosarcoma | 2 (3%) | ||
Ewing sarcoma | 1 (1%) | |||
PNET tumor | 1 (1%) | |||
Other sites | Orbit | Melanoma | 1 (1%) | |
Rhabdomyosarcoma | 1 (1%) | |||
PNET tumor | 1 (1%) | |||
Spine | Neuroblastoma | 2 (3%) | ||
Skull base | Chordoma | 1 (3%) | ||
Oropharynx | Rhabdomyosarcoma | 1 (1%) | ||
Extremity | Rhabdomyosarcoma | 1 (1%) | ||
Sub- and supradiaphragmatic Hodgkin lymphoma | 1 (1%) | |||